Time points of ADAMTS13 conformation analyzed in remission in patients after treatment with elective anti-CD20
| . | Peak ADAMTS13 (n = 33) . | 3 mo (n = 15) . | Peak = 3 mo∗ (n = 8) . |
|---|---|---|---|
| Open conformation | 5 (15%) | 12 (80%) | 2 (25%) |
| Closed conformation | 28 (85%) | 3 (20%) | 6 (75%) |
| . | Peak ADAMTS13 (n = 33) . | 3 mo (n = 15) . | Peak = 3 mo∗ (n = 8) . |
|---|---|---|---|
| Open conformation | 5 (15%) | 12 (80%) | 2 (25%) |
| Closed conformation | 28 (85%) | 3 (20%) | 6 (75%) |
ADAMTS13 conformation is shown at the peak ADAMTS13 activity and 3 months after elective anti-CD20 therapy.
Peak ADAMTS13 activity occurred at 3 months after elective anti-CD20 treatment.